NIH-funded research R01 grant

Investigating the role of kidney PCSK9 in nephrotic syndrome

Official title: Kidney PCSK9 in nephrotic syndrome

Funded at Rush University Medical Center · NIH-10750954 · Data updated 2026-11-12

This study is looking at how a protein called PCSK9 affects cholesterol levels in the kidneys of people with nephrotic syndrome, to help find better ways to spot and treat high cholesterol in these patients.

More Nephrotic Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startJanuary 1, 2021
Project endDecember 31, 2025
Funding year2024
Award (this year)$331,584
NIH project number5R01DK126926-04
Project IDNIH-10750954 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with nephrotic syndrome who experience elevated cholesterol levels.

Less likely to help

Patients without nephrotic syndrome or those who do not have issues with cholesterol levels may not benefit from this research.

What this research studies

This research focuses on understanding how PCSK9, a protein involved in cholesterol regulation, is expressed in the kidneys of patients with nephrotic syndrome. The study aims to explore the molecular mechanisms that lead to high cholesterol levels in these patients, particularly how PCSK9 secreted from kidney cells contributes to this condition. By analyzing kidney biopsies and using animal models, the researchers hope to identify specific markers that could help in early detection and treatment of hypercholesterolemia associated with nephrotic syndrome.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or reducing high cholesterol levels in patients with nephrotic syndrome.

How similar studies have gone: Previous studies have shown promising results in understanding the role of PCSK9 in cholesterol regulation, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Rush University Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Clement, Lionel Claudius — Rush University Medical Center
  • Study coordinator: Clement, Lionel Claudius

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.